Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Apricus Biosciences Inc.

TRADE

NASDAQ: APRIHealthcare / Drug Manufacturers - Other / USA
0.2900.00Vol 110 0331Y Perf -80.41%
Aug 21st, 2018 15:59
BID0.28 ASK0.29
Open0.29 Previous Close0.29
Pre-Market0.28 After-Trading0.28
 -0.01 -3.45%  -0.01 -3.45%
Target Price
2.65 
Analyst Rating
Hold 3.00
Potencial %
813.79 
Finscreener Ranking
★★+     48.33
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
★★★+     54.93
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★+     47.94
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Price Range Ratio 52wk %
1.29 
Earnings Date

Today's Price Range

0.280.29

 

52wk Range

0.253.34

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-27.50%
3 Months
0.00%
6 Months
-74.56%
1 Year
-80.41%
3 Years
-78.20%
5 Years
-86.64%

Quotes

Name / TickerPriceChg.Chg.%
APRI0.290.00000.00
AAPL215.04-0.4200-0.19
GOOG1 201.62-6.1500-0.51
MSFT105.98-0.8900-0.83
XOM78.830.02000.03
WFC58.96-0.0700-0.12
JNJ135.35-1.5300-1.12
FB172.620.12000.07
GE12.630.33002.68
JPM115.320.70000.61
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.60
Current Ratio 3.70
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -108.80
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin79.20
EBIT Margin-697.20
EBITDA Margin-677.00
Pre-tax Profit Margin-305.20
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio 0.70
PB Ratio 1.26
PS Ratios 79.92
Price to Cash Flow 26.00
Price to Free Cash Flow -0.70
Cash Flow Per Share -0.55
Price to Tangible Book1.26
Book Value per Share0.23
Enterprise Value (in ths.)-155
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-6 996.66
ROE last 12 Months -182.62
Return on Assets (5Y Avg) -161.77
ROA last 12 Months -135.01
Return on Capital (5Y Avg) -
ROC last 12 Months -182.62
Return on invested Capital Q -47.58
Return on invested Capital Y-45.76
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -53.21
Revenue Growth 5 Years -27.17
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018--0.10-
Q01 2018-0.10-0.14-40.00
Q04 2017-0.13-0.16-23.08
Q03 2017-0.15-0.30-100.00
Q02 2017-0.17-0.1511.76
Q01 20171.24-0.44-135.48
Q04 20160.01-0.04-500.00
Q03 2016-0.70-0.1972.86
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.100.00-
9/2018 QR-0.100.00-
12/2018 FY-0.400.00-
12/2018 FY-0.39-130.47Negative
Next Report Date15th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume110 033
Shares Outstanding (in ths.)23 440
Trades Count126
Dollar Volume30 416
Avg. Volume1 057 260
Avg. Weekly Volume190 898
Avg. Monthly Volume498 525
Avg. Quarterly Volume775 990

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

69%31%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x